Ampicillin Injection, Powder, For Solution
Product Images NDC 51662-1560

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ampicillin (NDC 51662-1560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial :labeling (51662 1560 Vial Labeling)

Vial :labeling (51662 1560 Vial Labeling)
This vial contains 2g of Ampicillin sodium USP equivalent to Ampicillin. The vial should be stored between 20°C and 25°C. Sterile water for the injection should be added before direct Intravenous use. The recommended adult dosage is between 250mg and 500mg every 6 hours, intravenously. For more information on indications, dosage, and precautions, refer to the accompanying insert. This product is manufactured in India and distributed by Ausromedics.*
FDA Label Image

Case Label (51662 1560 3 Case Labeling)

FDA Label Image

Seriliazed Labeling (51662 1560 3 Serialized Rfid Case Labeling)

FDA Label Image

Pouch Labeling (51662 1660 2 Pouch Labeling)

Pouch Labeling (51662 1660 2 Pouch Labeling)
This is a description of an injectable drug called "AMPICIL" in a vial size of 2 gm. The rest of the text seems to be product and batch information, including a code "a1 03 s02150025" and a prescription warning "RX ONLY".*
FDA Label Image

D1 (D1)

D1 (D1)
This is a dosage table showing the recommended dosage for bacterial meningitis and septicemia in neonates (less than or equal to 28 days of postnatal age). Dosage is based on gestational age and postnatal age, with different dosages recommended for different ranges. The highest recommended dosage is 150 mg/kg/day, administered in equally divided doses every 8 or 12 hours.*
FDA Label Image

D2 (D2)

D2 (D2)
This text appears to be a table with headers "Recommended Amount of Diluent", "Withdrawable Volume", and "Concentration (in mg/mL)". It lists four entries with different medication codes (55150-111-10, 55150-112-10, 55150-113-10, and 55150-114-20), corresponding recommended amounts of diluent, withdrawable volumes, and concentrations for different medication doses.*
FDA Label Image

D3 (D3)

D3 (D3)
This is a table displaying the stability periods of various diluent concentrations for a substance at room temperature (25°C) and in refrigerated conditions (4°C). The diluents used are Sterile Water for Injection, 0.9% Sodium Chloride Injection, USP, 5% Dextrose Injection, USP, 5% Dextrose and 0.45% Sodium Chloride Injection, USP, and Lactated Ringer's Injection, USP. The stability periods range from 1 to 72 hours depending on the diluent concentration and storage temperature.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.